ACTIVE SUBSTANCE / INN

BEXAROTENE

Brand name(s): Targretin, BEXAROTENE, TARGRETIN
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
ANDA210352
ANDA215398
ACTIVE SUBSTANCE
Bexarotene
REGULATORS
FDA · EMA
SPONSORS / MAH
H.A.C. Pharma, BAUSCH, AMNEAL
TOTAL APPLICATIONS
4
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BEXAROTENEANDA215398AMNEALPrescription
TARGRETINNDA021056BAUSCHPrescription
BEXAROTENEANDA210352CIPLADiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
TargretinH.A.C. PharmaAuthorised29/03/2001Lymphoma, T-Cell, Cutaneous

FULL INTELLIGENCE ON BEXAROTENE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →